|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.91 USD | +0.11% |
|
+0.17% | +76.09% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-25 | Apogee Therapeutics Insider Sold Shares Worth $3,500,640, According to a Recent SEC Filing | MT |
| Market Cap | 9.96B 8.7B 7.99B 7.45B 14.13B 948B 14.37B 96.24B 37.3B 465B 37.4B 36.59B 1,603B | P/E 2026 * |
-30.8x | P/E 2027 * | -23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 8.98B 7.85B 7.21B 6.72B 12.74B 855B 12.96B 86.77B 33.63B 419B 33.73B 32.99B 1,445B | EV / Sales 2026 * |
988x | EV / Sales 2027 * | 738x |
| Free-Float |
90.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Apogee Therapeutics, Inc.
| 1 day | +0.11% | ||
| 1 week | +0.17% | ||
| Current month | +0.14% | ||
| 1 month | +68.86% | ||
| 3 months | +57.59% | ||
| 6 months | +75.39% | ||
| Current year | +76.09% |
| 1 week | 132.61 |  | 133.85 |
| 1 month | 81.04 | | 133.85 |
| Current year | 60.35 | | 133.85 |
| 1 year | 34.34 | | 133.85 |
| 3 years | 14.19 | | 133.85 |
| 5 years | 14.19 | | 133.85 |
| 10 years | 14.19 | | 133.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 36 | 01/09/2022 | |
Jane Henderson
DFI | Director of Finance/CFO | 60 | 01/01/2023 |
Tim Piringer
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jennifer Fox
BRD | Director/Board Member | 54 | 22/06/2023 |
William Jones
BRD | Director/Board Member | 62 | 01/06/2023 |
| Director/Board Member | 36 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Sell | Chief Executive Officer | -80,000 | 0.1429% | ||
| 06-22 | Sell | Chief Technology Officer | -26,400 | 0.0471% | ||
| 06-10 | Sell | Chief Executive Officer | -20,000 | 0.0357% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +0.17% | +199.89% | - | 9.96B | |
| +0.46% | +5.91% | +1.69% | +6.95% | 49.15B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 40.23B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 34.55B | |
| +2.38% | +8.10% | +21.83% | +66.94% | 33.09B | |
| +1.20% | +2.02% | +9.79% | +32.43% | 25.19B | |
| +2.51% | +4.94% | - | - | 17.05B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.92B | |
| 0.00% | +0.26% | +13.31% | +18.72% | 13.83B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.26B | |
| Average | +1.09% | +5.80% | +85.21% | +103.24% | 25.22B | |
| Weighted average by Cap. | +1.20% | +6.47% | +93.08% | +130.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.09M 7.94M 7.29M 6.8M 12.9M 865M 13.11M 87.83M 34.04M 424M 34.13M 33.39M 1.46B | 12.5M 10.92M 10.03M 9.35M 17.73M 1.19B 18.03M 121M 46.8M 584M 46.94M 45.92M 2.01B |
| Net income | -318M -277M -255M -238M -450M -30.23B -458M -3.07B -1.19B -14.83B -1.19B -1.17B -51.09B | -416M -364M -334M -312M -591M -39.65B -601M -4.02B -1.56B -19.45B -1.56B -1.53B -67B |
| Net Debt | -980M -856M -786M -733M -1.39B -93.25B -1.41B -9.46B -3.67B -45.74B -3.68B -3.6B -158B | -740M -647M -594M -554M -1.05B -70.47B -1.07B -7.15B -2.77B -34.56B -2.78B -2.72B -119B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $132.91 | +0.11% | 2,998,799 |
| 01/07/26 | $132.77 | +0.03% | 3,598,433 |
| 30/06/26 | $132.73 | +0.09% | 5,436,413 |
| 29/06/26 | $132.61 | +0.05% | 3,494,734 |
| 26/06/26 | $132.55 | -0.10% | 5,109,502 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- APGE Stock
Select your edition
All financial news and data tailored to specific country editions
